- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Chronic kidney disease associated pruritus
- Meeting Date: November 2023
- Public Summary Document (PSD) November 2023 PBAC Meeting - (PDF 947KB)
- Public Summary Document (PSD) November 2023 PBAC Meeting - (Word 286KB)
Difelikefalin – November 2023
Difelikefalin: Solution for I.V. injection 50 micrograms in 1 mL vial; Korsuva®
Last updated
1 March 2024